| 0 | 💬 0 |
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.
(nejm.org)
|
New England Journal of Medicine 2026-04-09 | #vaccination #antibody #immunogenicity #safety #yellow fever | |
| 0 | 💬 0 |
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.
(nejm.org)
|
New England Journal of Medicine 2026-04-09 | #antibody #clinical trial #immunotherapy #thrombocytopenia |